MENU
+Compare
AMGN
Stock ticker: NASDAQ
AS OF
Dec 18, 10:43 AM (EDT)
Price
$265.88
Change
-$0.07 (-0.03%)
Capitalization
151.69B

AMGN Amgen Forecast, Technical & Fundamental Analysis

a manufacturer of human therapeutic products based on cellular biology

AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for AMGN with price predictions
Dec 17, 2024

AMGN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on December 16, 2024

AMGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where AMGN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 12, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on AMGN as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AMGN turned negative on December 16, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

AMGN moved below its 50-day moving average on November 11, 2024 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for AMGN moved below the 200-day moving average on December 13, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AMGN entered a downward trend on November 15, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AMGN's P/B Ratio (24.331) is slightly higher than the industry average of (5.632). P/E Ratio (22.661) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (2.526) is also within normal values, averaging (3.004). Dividend Yield (0.031) settles around the average of (0.164) among similar stocks. P/S Ratio (5.402) is also within normal values, averaging (3.643).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

View a ticker or compare two or three
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AMGN is expected to report earnings to fall 9.68% to $5.04 per share on February 04

Amgen AMGN Stock Earnings Reports
Q4'24
Est.
$5.04
Q3'24
Beat
by $0.47
Q2'24
Missed
by $0.01
Q1'24
Beat
by $0.07
Q4'23
Beat
by $0.12
The last earnings report on October 30 showed earnings per share of $5.58, beating the estimate of $5.11. With 61.49K shares outstanding, the current market capitalization sits at 151.69B.
A.I.Advisor
published Dividends

AMGN paid dividends on December 09, 2024

Amgen AMGN Stock Dividends
А dividend of $2.25 per share was paid with a record date of December 09, 2024, and an ex-dividend date of November 18, 2024. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of human therapeutic products based on cellular biology

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
One Amgen Center Drive
Phone
+1 805 447-1000
Employees
26700
Web
https://www.amgen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEYS36.461.17
+3.32%
Weyco Group
FTEK1.01N/A
-0.49%
Fuel Tech
CNC57.81-1.36
-2.30%
Centene Corp
PTEN7.34-0.20
-2.65%
Patterson-UTI Energy
NX26.44-1.33
-4.79%
Quanex Building Products Corp

AMGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
-0.21%
PFE - AMGN
35%
Loosely correlated
+4.67%
BIIB - AMGN
33%
Loosely correlated
+0.10%
ABBV - AMGN
29%
Poorly correlated
+2.18%
JNJ - AMGN
26%
Poorly correlated
+1.78%
GILD - AMGN
25%
Poorly correlated
+0.81%
More